Fatima Shubber, Managing Director, Shubber Scientific Bureau
Leadership within the pharmaceutical landscape demands more than business expertise, it requires responsibility, foresight, and a profound understanding of healthcare’s societal impact. Leaders in this space must navigate regulation, innovation, and patient needs with equal precision, shaping pathways that enable access, trust, and meaningful progress. True leadership emerges not only through organizational growth, but through the ability to influence the health outcomes of communities and strengthen healthcare ecosystems over time. It is within this context that Fatima Shubber, Managing Director of Shubber Scientific Bureau, stands as a defining example of modern leadership.
Coming from a respected business legacy, Fatima has transformed continuity into impact, bridging tradition with innovation and demonstrating what purposeful leadership can achieve in Iraq’s rapidly evolving pharmaceutical sector.
Iraqs Pharmaceutical Industry Challenges & Opportunities
By: Rachita Sharma, Managing Editor
The Iraqi pharmaceutical industry, valued at over $3 billion in 2024, is rapidly growing but remains heavily dependent on
Key Elements to Consider While Building Future-Ready Finance Teams
By: Mac Weaver, SVP & GM - APAC, BlackLine
Mac Weaver, SVP and GM APAC at BlackLine, is an important participant in the corporate operating committee, influencing
By: Sanjay Sehgal, Chairman & CEO, Aziro (Formerly MSys Technologies)
Sanjay Sehgal has over 20 years of management and entrepreneurial expertise in the enterprise
By: Manish Walia, Head-Industrial Automation Business Group, Delta Electronics India
With experience of over three decades and enormous passion, Manish Walia heads the
By: Dr Nishant Saxena, CEO - Emerging Markets & Europe, Cipla
Nishant Saxena, a senior pharmaceutical executive, has a strong history of achieving step-change results. With over two decades of experience
Top 10 Leaders in Pharmaceuticals from Iraq - 2026
Pharmaceutical leadership in Iraq is being shaped by individuals who combine deep scientific understanding with strategic business acumen and a strong commitment to healthcare access. The leaders of this organization have driven the sector's evolution from dependence on imported goods to establishing sustainable manufacturing processes and achieving operational excellence through local distribution and international market partnerships. The team consists of professionals from pharmacy, medicine, engineering and management fields who provide different insights that help organizations make better choices in dealing with complicated rules and market challenges.
Iraq's pharmaceutical leaders achieve quality-driven growth as their important defining characteristic. The pharmaceutical leaders have promoted international manufacturing standards together with modern production infrastructure investments and development of quality management systems, which ensure safe product delivery through consistent and compliant operations. Their leadership has enabled the scaling of operations across multiple therapeutic areas while maintaining affordability and reliability in a price-sensitive market.
"Leaders in Iraq’s pharmaceutical sector are driving progress by combining scientific expertise, ethical leadership, and a commitment to expanding access to quality medicines"
Their work in developing partnerships and entering new markets holds equal value to their other responsibilities. Through their partnerships with global pharmaceutical manufacturers, research institutions and technology providers these leaders achieved technology transfer, product expansion and supply chain enhancement. They support organizations with their work on regulatory requirements, efforts to establish better drug monitoring systems and participation in discussions which aim to build a better national health system.
Pharmaceutical leaders in Iraq place greater importance on ethical leadership and social responsibility because they view healthcare as essential to both economic development and societal progress. Their work helps to create better workforces and transfer knowledge while making it easier for patients to get vital medicines. The group of people here are developing a stronger Pharmaceutical Industry which helps Iraq move forward as a regional healthcare developing nation.
CEO Insights Asia in this issue presents a list of ‘Top 10 Leaders in Pharmaceuticals from Iraq - 2026' who have leveraged their extensive industry expertise and experience in offering effective skills to the market. The following list has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable knowledge.
| Company Logo | Company Management | Company Name | Company Description |
|---|---|---|---|
![]() |
Ahmed Lami, Co-Founder | Safemed Pharmaceutical | He has been working in the medical field for several years, with a focus on the pharmaceutical sector, and his experience spans operations, strategic planning, and cross-functional coordination, supporting partnerships, and more |
![]() |
Ahmed Talal , CEO | Global Pharma Iraq | A pharmacist and a chief executive with over 15 years of experience in the pharmaceutical industry, he brings expertise in sales and healthcare communication |
![]() |
Dr Amer Qasim , Chairman & CEO | Farabi pharma | With industry expertise, he focuses on strengthening manufacturing excellence, expanding market presence, and ensuring the delivery of quality, affordable medicines while upholding strong governance and ethical standards |
![]() |
Fatima Shubber, Managing Director | Shubber Scientific Bureau | A pharmacist and industry leader, she has transformed the company into a trusted representative of global pharmaceutical brands, driving partnerships, innovation, and patient-centered initiatives that have helped shape Iraq’s healthcare landscape |
Other Issues
We use cookies to ensure you get the best experience on our website. Read more...